Do you want to read an article? Please log in or register.
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study
Further Publications Immunology
Related content
Systemic Lupus Erythematosus
Effects of sodium-glucose transporter 2 inhibitors in patients with lupus nephritis: a before-and-after retrospective cohort study
Rheumatology (Oxford)
Ramírez-Mulhern I, Navarro-Sánchez V, Rivero-Otamendi E, Sánchez-Mejía DE, Zavala-Miranda MF, Mejia-Vilet JM
doi: 10.1093/rheumatology/keaf548
Systemic Lupus Erythematosus
Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort study
Rheumatology (Oxford)
Kharouf F, Mehta P, Li Q, Gladman DD, Whittall Garcia LP, Touma Z
doi: 10.1093/rheumatology/keaf464
Systemic Lupus Erythematosus
Secukinumab in active lupus nephritis: Results from phase III, randomised, placebo-controlled study (SELUNE) and open-label extension study
Rheumatology (Oxford)
Zhao MH, Cons Molina F, Aroca G, Tektonidou MG, Mathur A, Tangadpalli R, Sun R, Martin R, Pellet P, Ngoc Phuong Huynh T
doi: 10.1093/rheumatology/keaf536
Melanoma and Skin Cancer
Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients
Ann Dermatol Venereol
David C, Coquelle C, Le Corre Y, L'Orphelin JM, Nardin C, Aubin F, Cassecuel J, Dreno B, Wierzbiecka-Hainault E, Bens G, Beneton N, Dinulescu M, Kervarrec T, Saiag P, Blom A, Samimi M
doi: 10.1016/j.annder.2025.103411
Immunodeficiency
A Multicentric Clinical Study to Evaluate Pharmacokinetics, Efficacy, and Safety of Immune Globulin Subcutaneous 20% Weekly/Biweekly Dosing in Treatment-Experienced Patients and Loading/Weekly Maintenance Dosing in Treatment-Naïve Patients with Primary Immunodeficiency
J Clin Immunol
Lumry WR, Palumbo M, Hsu C, Hussain I, McNeil D, Bridges T, Wedner HJ, Scarupa M, Mondou E, Nanaware-Kharade N, Hanna K, Coll MQ, Oliveras J
doi: 10.1007/s10875-025-01952-5
Further Publications Rheumatology
Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study
Rheumatology (Oxford)
Retuerto-Guerrero M, Morales CM, Pareja-Martínez A, Molina-Esteban N, Puig-Buendia J, Postigo Llorente C, Cofiño AL, Martínez-Barrio J, Vidal-Montal P, Sendagorta Cudos E, Martos Cabrera L, González Arribas G, Calvo Alén J, De Dios JR, Blanco Madrigal JM, Corral JB, Claudio Oliva A, Casasempere PV, Castellanos Gonzalez M, Fito Manteca MC, Capusan TM, Ordás Calvo C, Ramos Rodríguez D, Sanchez Herrero A, Ortega-Valín L, Álvarez ED
doi: 10.1093/rheumatology/keaf662
COMMENTED
Systemic Lupus Erythematosus
Incidence of glaucoma in patients with systemic lupus erythematosus: a nationwide cohort study in South Korea
★ 1
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Br J Ophthalmol
Kim JH, Kim Y, Oraha KM, Park HM, Kim YJ, Lim HW, Sung YK, Welsbie DS, Lee WJ
doi: 10.1136/bjo-2025-327897
Systemic Lupus Erythematosus
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort
Arthritis Res Ther
Kandane-Rathnayake R, Louthrenoo W, Lau CS, Hamijoyo L, Cho J, Lateef A, Luo SF, Wu YJ, Navarra S, Zamora L, Li Z, Chen YH, Oon S, Chan M, Sockalingam S, Hao Y, Zhang Z, Bae SC, Kikuchi J, Takeuchi T, Katsumata Y, Basnayake B, Goldblatt F, O'Neill S, Pek Ling Ng K, Tugnet N, Sapsford M, Poh YJ, Tee C, Tee M, Ohkubo N, Lefeber AO, Shisha T, Tanaka Y, Golder V, Nikpour M, Hoi A, Gergely P, Morand E
doi: 10.1186/s13075-025-03622-8
Melanoma and Skin Cancer
Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)
Br J Dermatol
Nardin C, Cavalieri C, Lebbé C, Gérard E, Puyraveau M, Vergara R, Maubec E, Kramkimel N, Lesage C, Rouanet J, Bonniaud B, Puzenat E, Popescu D, Baroudjian B, Le Corre Y, Saiag P, Brunet Possenti F, Saint-Jean M, Montaudié H, Amini-Adle M, Belkaid S, Grange F, Mansard S, Béjar CL, Darras S, Pages C, Tournier E, Funck-Brentano E, Aubin F
doi: 10.1093/bjd/ljaf268